Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

i(17q) in myeloid malignancies

Identity

Note
  • an isochromosome 17 results in a loss of the short arm (17p) and duplication of the long arm (17q) leading to a single copy of 17p and three copies of 17q
  • an i(17q), usually observed in a complex karyotype, has been reported in solid tumors and in various types of hematological diseases: acute and chronic myeloid leukemias, acute lymphoid leukemiasand chronic lymphoid leukemias, and Hodgkin and non-Hodgkin lymphomas
  • inchronic myeloid leukemia, i(17q) is a frequent and well known secondary anomaly, either solely in 10% of cases, or with other additional anomalies , in at least another 10% of cases, in particular with +8.
  •  
      i(17q) G- banding (left) - Courtesy Jean-Luc Lai (top) and Diane H. Norback, Eric B. Johnson, and Sara Morrison-Delap, UW Cytogenetic Services (middle and bottom); and R- banding (right) - top: Editor, bottom: Courtesy Jacques Boyer.

    Clinics and Pathology

    Disease myeloproliferative/myelodysplastic diseases (MPD/MDS)
    Phenotype / cell stem origin previous studies on isolated i(17q) have suggested this aberration was associated with chronic myeloid abnormalities with a high rate of progression to ANLL; a new clinico-pathological entity in which i(17q) is the sole abnormality has been reported in a mixed myeloproliferative disorder / myelodysplastic syndrome with an aggressive course; ifteen patients were included in this study classified as chronic myeloid malignancy at initial presentation: these features were not confirmed after a negative molecular BCR-ABL analysis in all cases studied (eleven patients)
    Etiology i(17q) as sole cytogenetic aberration represents only 1% of cases in myeloid malignancies
    Cytology a severe hyposegmentation of neutrophil nuclei (pseudo-Pelger Huet neutrophils (PHH)) and a prominence of the monocyte/macrophage lineage has been noted; other studies have identified an association between hyposegmented neutrophils and loss of 17p (called 17p- syndrome), always included in complex karyotypes; the i(17q) appeared to be a part of the malignant clone as demonstrated in cases available for a FISH analysis: all myeloid cell lines observed contained the abnormal i(17q), whereas none of the lymphocytes were affected
    Prognosis by standard Kaplan-Meier analysis, the median survival was 2.5 years (range 0.85-5.25 years)

    Genes involved and Proteins

    Note
  • the underlying molecular defect that produces the isolated i(17q) is unknown : breakage of the proximal p arm (17p11.2) with rejoining of both centromere-containing chromatids and subsequent inactivation of one centromere; breakpoints could involve important genetic material whose disruption could result in oncogene or tumor suppression gene deregulation
  • in understanding the specific i(17q) phenotype, loss of genes localized on 17p were suggested as p53 (17p13.1); a direct correlation between p53 loss and PHH neutrophils was found in a series of MDS and ANLL with 17p- syndrome
  • External links

    Other databasei(17q) in myeloid malignancies Mitelman database (CGAP - NCBI)

    Bibliography

    Abnormalities of chromosome No. 17 in myeloproliferative disorders.
    Borgstrˆm GH, Vuopio P, de la Chapelle A
    Cancer genetics and cytogenetics. 1982 ; 5 (2) : 123-135.
    PMID 6950807
     
    Dicentric chromosome 17 in patients with leukemia.
    Testa JR, Cohen BC
    Cancer genetics and cytogenetics. 1986 ; 23 (1) : 47-52.
    PMID 3461878
     
    Isochromosome 17q in Ph1-negative leukemia: a clinical, cytogenetic, and molecular study.
    Becher R, Carbonell F, Bartram CR
    Blood. 1990 ; 75 (8) : 1679-1683.
    PMID 2328318
     
    Cytogenetics in multiple myeloma: are we studying the 'right' cells?
    Weh HJ, Fiedler W, Hossfeld DK
    European journal of haematology. 1990 ; 45 (4) : 236-237.
    PMID 2226744
     
    Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoˆØesis and a high incidence of P53 mutations.
    Lai JL, Preudhomme C, Zandecki M, Flactif M, Vanrumbeke M, Lepelley P, Wattel E, Fenaux P
    Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 1995 ; 9 (3) : 370-381.
    PMID 7885035
     
    Granulocytes with segmented nucleus retain normal chromosomes 17 in Philadelphia chromosome-positive chronic myeloid leukemia with i(17q) and pseudo-Pelger anomaly. A case report studied with fluorescence in situ hybridization.
    Fugazza G, Bruzzone R, Puppo L, Sessarego M
    Cancer genetics and cytogenetics. 1996 ; 90 (2) : 166-170.
    PMID 8830728
     
    The 17p-syndrome: a distinct myelodysplastic syndrome entity?
    Jary L, Mossafa H, Fourcade C, Genet P, Pulik M, Flandrin G
    Leukemia & lymphoma. 1997 ; 25 (1-2) : 163-168.
    PMID 9130624
     

    Contributor(s)

    Written02-2000Chrystèle Bilhou-Nabera

    Citation

    This paper should be referenced as such :
    Bilhou-Nabera C . i(17q) in myeloid malignancies. Atlas Genet Cytogenet Oncol Haematol. February 2000 .
    URL : http://AtlasGeneticsOncology.org/Anomalies/i17qID1038.html

    © Atlas of Genetics and Cytogenetics in Oncology and Haematology
    indexed on : Mon May 12 18:11:40 2008


    Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

    For comments and suggestions or contributions, please contact us

    j.l.huret@chu-poitiers.fr.